RxDoctor Payments Data

Sheryl List

Psychiatric/Mental Health · Cincinnati, OHNPI 1962020875

Payments from drug & device makers

$4,029in general payments, 2019–2025

Across 259 payments — averaging $15.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$761
  • Otsuka America Pharmaceutical, Inc.$635
  • Takeda Pharmaceuticals U.S.A., Inc.$520
  • Noven Therapeutics, LLC$387
  • Teva Pharmaceuticals USA, Inc.$318
  • Vanda Pharmaceuticals Inc.$292
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$3,94698%
  • Education$842%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,029 in reported general payments places this provider in the 85th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio

Medicare billing

Part B allowed, 2024
$18,304
Medicare patients
53
Services billed
387

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl20$22,652
RexultiBrexpiprazole12$17,209
QuviviqDaridorexant Hcl14$6,636
Quetiapine Fumarate81$2,302
Clomipramine Hcl27$2,256
Desvenlafaxine Succinate ErDesvenlafaxine Succinate37$1,730
Risperidone94$1,712
Perphenazine-AmitriptylinePerphenazine/Amitriptyline Hcl12$1,579
Lamotrigine45$1,194
Aripiprazole48$1,141
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine29$1,129
Olanzapine28$809
Trazodone Hcl51$808
Vilazodone Hcl12$806
Mirtazapine29$678

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$761$22,65220 claims
Otsuka America Pharmaceutical, Inc.Rexulti$635$17,20912 claims
Idorsia Pharmaceuticals US IncQuviviq$55$6,63614 claims
Lilly USA, LLCOlanzapine$15$80928 claims
Almatica Pharma LLCSertraline Hcl$19$34354 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →